Publicado 6 números por año
ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472
Indexed in
The Role of Tec Family Kinases in Mononuclear Phagocytes
SINOPSIS
Mononuclear phagocytes, including monocytcs, macrophages, and dendritic cells, play an important role in innate and adaptive immune responses and are important regulators of the inflammatory response. Among these, monocytes/macrophages are involved in virtually all aspects of inflammation, ranging from the detection and phagocytosis of pathogens up to the resolution of inflammation and repair of tissue damage. The stimulation of cell surface receptors, such as Toll-like receptors, leads to the initiation of intracellular signal transduction pathways regulating macrophagc activation and effector functions. One group of signaling molecules stimulated on macrophage activation is formed by the Tec kinasc family, which consists of five members (Bmx, Btk, Itk, Rlk, and Tec) and constitutes the second-largest family of nonreceptor protein tyrosine kinases in the immune system. Some Tec kinases have been shown to be major regulators of antigen receptor signaling in lymphocytes, and deficiencies in Tec family kinases cause several immunological defects in humans and mice. Much less is known about the role of Tec family kinases in the myeloid branch of the hematopoietic system. In this review, we discuss the current knowledge about the role of Tec family kinases in monocytes/macrophages, in dendritic cells, and in osteoclasts.
-
Tai Yu-Tzu, Chang Betty Y., Kong Sun-Young, Fulciniti Mariateresa, Yang Guang, Calle Yolanda, Hu Yiguo, Lin Jianhong, Zhao Jian-Jun, Cagnetta Antonia, Cea Michele, Sellitto Michael A., Zhong Mike Y., Wang Qiuju, Acharya Chirag, Carrasco Daniel R., Buggy Joseph J., Elias Laurence, Treon Steven P., Matsui William, Richardson Paul, Munshi Nikhil C., Anderson Kenneth C., Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma, Blood, 120, 9, 2012. Crossref
-
Herman Sarah E. M., Mustafa Rashida Z., Gyamfi Jennifer A., Pittaluga Stefania, Chang Stella, Chang Betty, Farooqui Mohammed, Wiestner Adrian, Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL, Blood, 123, 21, 2014. Crossref
-
Lougaris Vassilios, Baronio Manuela, Vitali Massimiliano, Tampella Giacomo, Cattalini Marco, Tassone Laura, Soresina Annarosa, Badolato Raffaele, Plebani Alessandro, Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation, Journal of Allergy and Clinical Immunology, 133, 6, 2014. Crossref
-
Ellmeier Wilfried, Abramova Anastasia, Schebesta Alexandra, Tec family kinases: regulation of FcεRI-mediated mast-cell activation, FEBS Journal, 278, 12, 2011. Crossref
-
Horwood Nicole J., Urbaniak Ania M., Danks Lynett, Tec Family Kinases in Inflammation and Disease, International Reviews of Immunology, 31, 2, 2012. Crossref
-
Cenni Bruno, Gutmann Sascha, Gottar-Guillier Marie, BMX and Its Role in Inflammation, Cardiovascular Disease, and Cancer, International Reviews of Immunology, 31, 2, 2012. Crossref
-
Hussain Alamdar, Yu Liang, Faryal Rani, Mohammad Dara K., Mohamed Abdalla J., Smith C. I. Edvard, TEC family kinases in health and disease - loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK, FEBS Journal, 278, 12, 2011. Crossref
-
Teocchi Marcelo A., Domingues Ramalho Vanessa, Abramczuk Beatriz M., D'Souza‐Li Lília, Santos Vilela Maria Marluce, BTK mutations selectively regulate BTK expression and upregulate monocyte XBP1 mRNA in XLA patients , Immunity, Inflammation and Disease, 3, 3, 2015. Crossref
-
Swisher Jennifer F. A., Feldman Gerald M., The many faces of FcγRI: implications for therapeutic antibody function, Immunological Reviews, 268, 1, 2015. Crossref
-
Ormsby Tereza, Schlecker Eva, Ferdin Janina, Tessarz Anja Sibylle, Angelisová Pavla, Köprülü Afitap Derya, Borte Michael, Warnatz Klaus, Schulze Ilka, Ellmeier Wilfried, Hořejší Václav, Cerwenka Adelheid, Btk is a positive regulator in the TREM-1/DAP12 signaling pathway, Blood, 118, 4, 2011. Crossref
-
Nahum Amit, Manson David, Ngan Bo, Atypical presentation and manifestations in X-linked agammaglobulinemia patients with novelBTKmutations, LymphoSign Journal, 2, 2, 2015. Crossref
-
Boucheron Nicole, Ellmeier Wilfried, The Role of Tec Family Kinases in the Regulation of T-helper-cell Differentiation, International Reviews of Immunology, 31, 2, 2012. Crossref
-
Kleino Iivari, Järviluoma Annika, Hepojoki Jussi, Huovila Ari Pekka, Saksela Kalle, Buday Laszlo, Preferred SH3 Domain Partners of ADAM Metalloproteases Include Shared and ADAM-Specific SH3 Interactions, PLOS ONE, 10, 3, 2015. Crossref
-
Zwolanek Florian, Riedelberger Michael, Stolz Valentina, Jenull Sabrina, Istel Fabian, Köprülü Afitap Derya, Ellmeier Wilfried, Kuchler Karl, Gaffen Sarah L., The Non-receptor Tyrosine Kinase Tec Controls Assembly and Activity of the Noncanonical Caspase-8 Inflammasome, PLoS Pathogens, 10, 12, 2014. Crossref
-
Park Jin Kyun, Byun Joo-Yun, Park Ji Ah, Kim Yu-Yon, Lee Ye Ji, Oh Jeong In, Jang Sun Young, Kim Young Hoon, Song Yeong Wook, Son Jeewoong, Suh Kwee Hyun, Lee Young-Mi, Lee Eun Bong, HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis, Arthritis Research & Therapy, 18, 1, 2016. Crossref
-
Köprülü Afitap Derya, Kastner Renate, Wienerroither Sebastian, Lassnig Caroline, Putz Eva Maria, Majer Olivia, Reutterer Benjamin, Sexl Veronika, Kuchler Karl, Müller Mathias, Decker Thomas, Ellmeier Wilfried, Lenz Laurel L., The Tyrosine Kinase Btk Regulates the Macrophage Response to Listeria monocytogenes Infection, PLoS ONE, 8, 3, 2013. Crossref
-
Ramírez Carolina, Díaz-Toro Yira, Tellez Jair, Castilho Tiago M., Rojas Ricardo, Ettinger Nicholas A., Tikhonova Irina, Alexander Neal D., Valderrama Liliana, Hager Janet, Wilson Mary E., Lin Aiping, Zhao Hongyu, Saravia Nancy G., McMahon-Pratt Diane, Milon Genevieve, Human Macrophage Response to L. (Viannia) panamensis: Microarray Evidence for an Early Inflammatory Response, PLoS Neglected Tropical Diseases, 6, 10, 2012. Crossref
-
Tadmor Tamar, Welslau Manfred, Hus Iwona, A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia, Expert Review of Hematology, 11, 1, 2018. Crossref
-
Boucheron Nicole, Tec, in Encyclopedia of Signaling Molecules, 2018. Crossref
-
Mirsafian Hoda, Ripen Adiratna Mat, Leong Wai-Mun, Chear Chai Teng, Bin Mohamad Saharuddin, Merican Amir Feisal, Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency, Scientific Reports, 7, 1, 2017. Crossref
-
Boucheron Nicole, Tec, in Encyclopedia of Signaling Molecules, 2016. Crossref
-
Fan Zhe, Wang Yan, Xu Xingxin, Wu Yonggui, Inhibitor of Bruton's tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators' production in high glucose-induced macrophages, International Immunopharmacology, 58, 2018. Crossref
-
Page Theresa H., Urbaniak Anna M., Espirito Santo Ana I., Danks Lynett, Smallie Timothy, Williams Lynn M., Horwood Nicole J., Bruton's tyrosine kinase regulates TLR7/8-induced TNF transcription via nuclear factor-κB recruitment, Biochemical and Biophysical Research Communications, 499, 2, 2018. Crossref
-
Merican Amir Feisal., Mirsafian Hoda, Ripen Adiratna Mat, Bin Mohamad Saharuddin, Studies of Body Systems, in Encyclopedia of Bioinformatics and Computational Biology, 2019. Crossref
-
Vijayan Vijith, Baumgart-Vogt Eveline, Naidu Srivatsava, Qian Guofeng, Immenschuh Stephan, Bruton’s Tyrosine Kinase Is Required for TLR-Dependent Heme Oxygenase-1 Gene Activation via Nrf2 in Macrophages, The Journal of Immunology, 187, 2, 2011. Crossref
-
Sanaei Roozbeh, Rezaei Nima, Aghamohammadi Asghar, Delbandi Ali-Akbar, Tavasolian Parsova, Tajik Nader, Disturbed Transcription of TLRs’ Negative Regulators and Cytokines Secretion among TLR4- and 9-Activated PBMCs of Agammaglobulinemic Patients, Immunological Investigations, 48, 8, 2019. Crossref
-
Bradshaw J. Michael, The Src, Syk, and Tec family kinases: Distinct types of molecular switches, Cellular Signalling, 22, 8, 2010. Crossref
-
Zhang Wei, Zhou Ping, Jiang Xiao, Fan Zhe, Xu Xingxin, Wang Fei, Negative Regulation of Tec Kinase Alleviates LPS-Induced Acute Kidney Injury in Mice via theTLR4/NF-κB Signaling Pathway, BioMed Research International, 2020, 2020. Crossref
-
Bame Eris, Tang Hao, Burns Jeremy C, Arefayene Million, Michelsen Klaus, Ma Bin, Marx Isaac, Prince Robin, Roach Allie M, Poreci Urjana, Donaldson Douglas, Cullen Patrick, Casey Fergal, Zhu Jing, Carlile Thomas M, Sangurdekar Dipen, Zhang Baohong, Trapa Patrick, Santoro Joseph, Muragan Param, Pellerin Alex, Rubino Stephen, Gianni Davide, Bajrami Bekim, Peng Xiaomei, Coppell Alex, Riester Katherine, Belachew Shibeshih, Mehta Devangi, Palte Mike, Hopkins Brian T, Scaramozza Matthew, Franchimont Nathalie, Mingueneau Michael, Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells, Clinical & Translational Immunology, 10, 6, 2021. Crossref
-
Pulz Robert, Angst Daniela, Dawson Janet, Gessier Francois, Gutmann Sascha, Hersperger Rene, Hinniger Alexandra, Janser Philipp, Koch Guido, Revesz Laszlo, Vulpetti Anna, Waelchli Rudolf, Zimmerlin Alfred, Cenni Bruno, Design of Potent and Selective Covalent Inhibitors of Bruton’s Tyrosine Kinase Targeting an Inactive Conformation, ACS Medicinal Chemistry Letters, 10, 10, 2019. Crossref
-
Vogt Peter K., Hart Jonathan Ross, PI3K and STAT3: A New Alliance, Cancer Discovery, 1, 6, 2011. Crossref
-
Ma Bin, Metrick Claire M., Gu Chungang, Hoemberger Marc, Bajrami Bekim, Bame Eris, Huang Jiansheng, Mingueneau Michael, Murugan Paramasivam, Santoro Joseph C., Tang Hao, Wang Ti, Hopkins Brian T., Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors, Bioorganic & Medicinal Chemistry Letters, 60, 2022. Crossref
-
Dou Dou, Diao Yanyan, Sha Wenjie, Su Rongrong, Tong Linjiang, Li Wenjie, Leng Limin, Xie Lijuan, Yu Zhixiao, Song Haoming, Shen Zihao, Zhu Lili, Zhao Zhenjiang, Xie Hua, Chen Zhuo, Li Honglin, Xu Yufang, Discovery of Pteridine-7(8H)-one Derivatives as Potent and Selective Inhibitors of Bruton’s Tyrosine Kinase (BTK), Journal of Medicinal Chemistry, 65, 3, 2022. Crossref
-
Su Rongrong, Diao Yanyan, Sha Wenjie, Dou Dou, Yu Zhixiao, Leng Limin, Zhao Zhenjiang, Chen Zhuo, Li Honglin, Xu Yufang, Discovery of pyrrolo[1,2-a]quinoxalin-4(5H)-one derivatives as novel non-covalent Bruton’s tyrosine kinase (BTK) inhibitors, Bioorganic Chemistry, 126, 2022. Crossref
-
Hopkins Brian T., Bame Eris, Bajrami Bekim, Black Cheryl, Bohnert Tonika, Boiselle Carrie, Burdette Doug, Burns Jeremy C., Delva Luisette, Donaldson Douglas, Grater Richard, Gu Chungang, Hoemberger Marc, Johnson Josh, Kapadnis Sudarshan, King Kris, Lulla Mukesh, Ma Bin, Marx Isaac, Magee Tom, Meissner Robert, Metrick Claire M., Mingueneau Michael, Murugan Paramasivam, Otipoby Kevin L., Polack Evelyne, Poreci Urjana, Prince Robin, Roach Allie M., Rowbottom Chris, Santoro Joseph C., Schroeder Patricia, Tang Hao, Tien Eric, Zhang Fengmei, Lyssikatos Joseph, Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis, Journal of Medicinal Chemistry, 65, 2, 2022. Crossref
-
Wang Gaiqing, Guo Zhenni, Tong Lusha, Xue Fang, Krafft Paul R., Budbazar Enkhjargal, Zhang John H., Tang Jiping, TLR7 (Toll-Like Receptor 7) Facilitates Heme Scavenging Through the BTK (Bruton Tyrosine Kinase)–CRT (Calreticulin)–LRP1 (Low-Density Lipoprotein Receptor–Related Protein-1)–Hx (Hemopexin) Pathway in Murine Intracerebral Hemorrhage, Stroke, 49, 12, 2018. Crossref
-
Pal Singh Simar, Dammeijer Floris, Hendriks Rudi W., Role of Bruton’s tyrosine kinase in B cells and malignancies, Molecular Cancer, 17, 1, 2018. Crossref
-
Mendes‐Bastos Pedro, Brasileiro Ana, Kolkhir Pavel, Frischbutter Stefan, Scheffel Jörg, Moñino‐Romero Sherezade, Maurer Marcus, Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions, Allergy, 77, 8, 2022. Crossref